HIF1A and ischemic disease: Comprehending the pro-inflammatory T-cell response and anti-tumor immunity, along with the role of metabolic regulation through HIF-1α in chronic inflammation, cancer, and ischemic diseases, is crucial for developing therapeutic approaches [9].